Stifel maintains Buy on Denali Therapeutics stock, $37 target
Raymond James maintains CRM stock Strong Buy, $375 target
Cowen maintains buy on Compass Pathways, target $23
Newsletter
Subscribe to get the latest news, offers and special announcements.


